1. Home
  2. HTLD vs COLL Comparison

HTLD vs COLL Comparison

Compare HTLD & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

HOLD

Current Price

$12.25

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$23.26

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTLD
COLL
Founded
1978
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
HTLD
COLL
Price
$12.25
$23.26
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$11.50
$51.40
AVG Volume (30 Days)
674.8K
837.9K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$805,709,000.00
$780,567,000.00
Revenue This Year
N/A
$8.01
Revenue Next Year
$8.36
N/A
P/E Ratio
$174.71
N/A
Revenue Growth
N/A
23.62
52 Week Low
$7.00
$23.11
52 Week High
$16.64
$50.79

Technical Indicators

Market Signals
Indicator
HTLD
COLL
Relative Strength Index (RSI) 43.18 23.91
Support Level $11.75 N/A
Resistance Level $13.09 $35.89
Average True Range (ATR) 0.44 1.03
MACD 0.06 -0.09
Stochastic Oscillator 39.11 4.55

Price Performance

Historical Comparison
HTLD
COLL

About HTLD Heartland Express Inc.

Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: